flow trial semaglutide ppt 🚨 Journal Club: Review 🚨 The FLOW Trial, published in The New England Journal of Medicine (May 2024), evaluated the effects Get With the FLOW! in:

Each session lasts about 30 minutes, making it a convenient option for those with busy schedules

Molecular metabolism, 30, 72130

After stopping semaglutide, many individuals regain a significant portion of lost weight within a year if lifestyle habits are not sustained

In non-diabetic patients, the differential diagnosis is broader, encompassing serious acute illnesses, endocrine deficiencies, and rare conditions like insulinomas or non-islet cell tumor hypoglycemia (NICTH)

According to the MHRA-approved Summary of Product Characteristics (SmPC), semaglutide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis